Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 4/20 | 0.40 |
| ▸ | CLK1 | P49759 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 6/20 | 0.39 |
| ▸ | WDR77 | Q9BQA1 | 6/20 | 0.39 |
| ▸ | TGFBR1 | P36897 | 7/20 | 0.36 |
| ▸ | TGFBR2 | P37173 | 2/20 | 0.34 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13874137 | 0.87 | FLT3 (0.51) | FLT3CLK1DYRK1APRMT5WDR77 | |
| Hydrochloric Acid SCHEMBL3856691 | 0.86 | FLT3 (0.50) | FLT3CLK1DYRK1APRMT5WDR77 | |
| SCHEMBL3850124 | 0.85 | LTB4R (0.39) | FLT3CLK1DYRK1A | |
| SCHEMBL3847437 | 0.84 | L3MBTL1 (0.40) | FLT3CLK1DYRK1ATGFBR1TGFBR2 | |
| Hydrochloric Acid SCHEMBL3847766 | 0.84 | FLT3 (0.52) | FLT3CLK1DYRK1APRMT5WDR77 | |
| SCHEMBL3847634 | 0.82 | FLT3 (0.46) | FLT3CLK1DYRK1APRMT5WDR77 | |
| SCHEMBL13874145 | 0.82 | FLT3 (0.46) | FLT3CLK1DYRK1APRMT5WDR77 | |
| SCHEMBL13874112 | 0.82 | FLT3 (0.46) | FLT3CLK1DYRK1APRMT5WDR77 | |
| SCHEMBL3846791 | 0.82 | MAPK8 (0.45) | — | |
| SCHEMBL3846673 | 0.82 | FAAH (0.43) | CLK1DYRK1ATGFBR1TGFBR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2048142-A2 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | Eisai R&D Management Co., Ltd. (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-1382603-B1 | NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | EISAI R&D MAN CO LTD (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-7074801-B1 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | EISAI CO., LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-1382603-A1 | NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | Eisai Co., Ltd. (JP) | 2004-01-21 | — | — | EP | disclosed |